UNS unilife corporation

http://www.visiongain.com/Report/631/Pre-Filled-Syringes-World-Ma...

  1. 1,882 Posts.


    http://www.visiongain.com/Report/631/Pre-Filled-Syringes-World-Market-Outlook-2011-2021




    A new report by London-based business information company visiongain, predicts that world pre-filled syringe technology revenues will reach $3.9bn in 2015. That devices market generated $2.7bn (for the technology itself) in 2010, according to Pre-Filled Syringes: World Market Outlook 2011-2021, published in June 2011.




    Pre-filled drug syringes are injecting devices that remove the filling step from another container before administering the injection. That drug delivery format is increasing in commercial importance with the expanding use of biological drugs and vaccines worldwide.




    Expansion of the pre-filled syringe market will be dependent upon developments in syringe technologies and materials. Improvements to performance, product stability, convenience of use and cost-effectiveness will stimulate increasing use of pre-filled syringes and related devices this decade. Increased volume and viscosity handling capabilities and launches of devices that are easier to use are already benefiting sales of the devices and filled products.




    Dr Gordon Low, healthcare reports editor, said: "The advantages are great, with pre-filled syringes taking over from traditional formats. Pre-fillable syringes constitute one of the fastest growing markets in the drug delivery and pharmaceutical packaging industries."




    Visiongain forecasts that the pre-filled syringe technology and applications markets will expand steadily to 2021. The future of the pre-filled drug industry and market appears promising, with increasing demand in many therapeutic areas. This new study complements visiongain?s wide range of analytical reports in healthcare and other industry areas.



 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.